Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.12 | 6e-05 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |